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ABSTRACT 31 
Objectives: Rapid identification of Acinetobacter species is critical since members of 32 
the A. baumannii (Ab) group differ in antibiotic susceptibility and clinical outcomes. A. 33 
baumannii, A. pittii and A. nosocomialis can be identified by MALDI-TOF/MS, while 34 
the novel species A. seifertii and A. dijkshoorniae cannot. Low identification rates for A. 35 
nosocomialis have also been reported. We evaluated the use of MALDI-TOF/MS to 36 
identify isolates of A. seifertii and A. dijkshoorniae and revisited the identification of A. 37 
nosocomialis to update the Bruker taxonomy database. 38 
Methods: Species characterisation was performed by rpoB-clustering and MLSA. 39 
MALDI-TOF/MS spectra were recovered from formic acid/acetonitrile bacterial 40 
extracts overlaid with α-cyano-4-hydroxy-cinnamic acid matrix on a MicroflexLT in 41 
linear positive mode and 2,000-20,000 m/z range mass. Spectra were examined with the 42 
ClinProTools v2.2 software. Mean spectra (MSP) were created with the BioTyper 43 
software. 44 
Results: Seventy-eight Acinetobacter isolates representative of the Ab group were used 45 
to calculate the average spectra/species and generate pattern recognition models. 46 
Species-specific peaks were identified for all species, and MSPs derived from 3 A. 47 
seifertii, 2 A. dijkshoorniae and 2 A. nosocomialis strains were added to the Bruker 48 
taxonomy database, allowing successful identification of all isolates using spectra from 49 
either bacterial extracts or direct colonies, resulting in a positive predictive value (PPV) 50 
of 99.6% (777/780) and 96.8% (302/312), respectively. 51 
Conclusions: The use of post-processing data software identified statistically 52 
significant species-specific peaks to generate reference signatures for rapid accurate 53 
identification of species within the Ab group, providing relevant information for the 54 
clinical management of Acinetobacter infections. 55 
56 
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INTRODUCTION 57 
The use of matrix-assisted laser desorption ionisation-time of flight mass spectrometry 58 
(MALDI-TOF/MS) for the identification of bacterial species has been a major 59 
breakthrough in clinical microbiology. MALDI-TOF/MS has proven to be a rapid and 60 
accurate methodology highly relevant for the differentiation of closely related bacterial 61 
species that are otherwise indistinguishable by conventional phenotypic methods, 62 
providing an inexpensive alternative to the laborious and time-consuming molecular 63 
identification methods [1].  64 
Former members of the Acinetobacter baumannii (Ab) group (A. baumannii, A. 65 
nosocomialis and A. pittii) are virtually indistinguishable using conventional phenotypic 66 
tests while accurate species differentiation is achieved by sequencing of the RNA 67 
polymerase β-subunit (rpoB) gene, the DNA gyrase B (gyrB) gene and/or by multilocus 68 
sequence analysis (MLSA), all of which most likely constitute the current gold standard 69 
for molecular identification [2-4]. 70 
In a previous work, we evaluated and optimised the use of MALDI-TOF/MS for species 71 
identification of the former members of the Ab group and demonstrated that it was an 72 
accurate and reliable method [5]. Subsequent MALDI-TOF/MS studies by several other 73 
groups together with the recent technological advances in molecular methods (such as 74 
whole genome sequencing) have revealed a relative abundance of non-baumannii 75 
Acinetobacter species of the Ab group in clinical specimens, mostly involving A. 76 
nosocomialis and A. pittii isolates [6-11]. 77 
In the last few years the taxonomy of the genus Acinetobacter has undergone major 78 
modifications, with more than 18 new species having been described since 2014 [3]. In 79 
particular, two novel pathogenic species, A. seifertii and A. dijkshoorniae, have recently 80 
been included within the Ab group and, like the former members of the group, they can 81 
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be best differentiated by molecular methods [3, 12]. Identification of these novel species 82 
by MALDI-TOF/MS is not yet possible, since a thorough study that evaluates the 83 
distinctness of spectral signatures of all the species within the Ab group and provides 84 
reference spectra for the novel species is still lacking. In addition, several studies have 85 
shown that while the Bruker MALDI-TOF BioTyper system correctly identifies almost 86 
all A. baumannii and A. pittii isolates, identification rates for A. nosocomialis range at 87 
about 70%, suggesting that the Bruker database should be updated and further improved 88 
to allow efficient identification of all Acinetobacter species [8, 13, 14].  89 
The aim of the present study was to perform an in-depth analysis of the spectrum 90 
profiles of all the Acinetobacter species currently included in the Ab group, and 91 
generate reference spectra to allow accurate and reliable identification to the species 92 
level by MALDI-TOF/MS. 93 
MATERIALS and METHODS 94 
Bacterial isolates 95 
The present study included 78 isolates belonging to the five Acinetobacter species 96 
within the Ab group, A. baumannii (n=16), A. nosocomialis (n=24), A. pittii (n=15), A. 97 
dijkshoorniae (n=12) and A. seifertii (n=11), mainly obtained from clinical samples in 98 
different geographical locations over a period of 15 years (Supplementary Table S1). 99 
Isolates were identified at the species level by sequencing of the RNA polymerase β-100 
subunit (rpoB) gene and multilocus sequence analysis (MLSA), as described previously 101 
[3]. Isolates were preserved at -80°C in 10% skimmed milk until use. 102 
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Sample preparation and MALDI-TOF/MS data acquisition 103 
Bacterial cultures were grown overnight on Columbia sheep blood agar (Becton 104 
Dickinson, Heidelberg, Germany) at 37ºC and subjected to ethanol-formic acid 105 
extraction according to [5].  106 
One microliter of each bacterial extract was spotted onto a MALDI target plate (MSP 96 107 
target ground steel; Bruker Daltonics, Bremen, Germany) and air-dried at room 108 
temperature. Each spotted sample was then overlaid with 1 µL of a saturated matrix 109 
solution (α-cyano-4-hydroxy-cinnamic acid; Bruker Daltonics) in 50% acetonitrile-110 
2.5% trifluoroacetic acid (Sigma-Aldrich chemical Co., Madrid, Spain) and air-dried.  111 
For MALDI-TOF/MS analysis performed directly from grown bacterial colonies, a 112 
small fraction of a single colony was spotted onto the MALDI target plate, carefully 113 
spread and subsequently overlaid with 1 µl of matrix. 114 
MALDI-TOF/MS was conducted in a Microflex LT (Bruker Daltonics) benchtop 115 
instrument as described previously [5]. Bacterial extracts from all isolates were spotted 116 
5 times onto a MALDI target plate and each spot was measured twice, resulting in 10 117 
mass spectra for each individual isolate. Direct colony samples were spotted twice, and 118 
each spot was also measured twice, resulting in 4 mass spectra for each individual 119 
isolate. 120 
MALDI-TOF/MS data analysis 121 
Spectra from bacterial extracts were loaded into the ClinProTools software (version 2.2; 122 
Bruker Daltonics) and prepared for analysis with the following parameters: 800 123 
resolution, Top Hat baseline subtraction with a 10% minimal baseline width and no data 124 
reduction. Null spectra and noise spectra exclusion with a noise threshold of 2.00 were 125 
both enabled and spectra grouping was also supported. Peak selection and average peak 126 
list calculation ranged from 2,000 to 10,000 mass to charge ratio values (m/z), and 127 
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recalibration was performed with a 1,000 parts per million (ppm) maximal peak shift 128 
and 30% match to calibrant peaks. Non-recalibrated spectra were excluded. 129 
m/z values from average spectra were identified according to their statistical 130 
significance, as determined by the different statistical tests supported by ClinProTools: 131 
Anderson-Darling test, t-/ANOVA test and Wilcoxon/Krustal-Wallis test. Informative 132 
peaks were those showing a significant difference among all species as described 133 
previously [15]. 134 
For the generation and validation of pattern recognition models, the 78 isolates were 135 
divided into two sets – (i) a reference set containing 40 isolates: A. baumannii (n=7), A. 136 
nosocomialis (n=13), A. pittii (n=8), A. dijkshoorniae (n=6) and A. seifertii (n=6); and 137 
(ii) a validation set containing 38 isolates: A. baumannii (n=9), A. nosocomialis (n=11), 138 
A. pittii (n=7), A. dijkshoorniae (n=6) and A. seifertii (n=5). Selection was performed on 139 
the grounds of the spectral analysis in order to include as much diversity as possible 140 
within both sets, prioritising the reference set whenever an equitable distribution was 141 
not possible. Classification models were generated using the genetic algorithm (GA), 142 
supervised neural network (SNN), and QuickClassifier (QC) algorithms with default 143 
settings. The recognition capability and cross validation values were calculated to 144 
demonstrate the reliability and accuracy of the model. 145 
Bacterial identification 146 
Spectra were analysed with the MALDI BioTyper software (version 3.1; Bruker 147 
Daltonics) using the pre-processing and BioTyper main spectrum (MSP) identification 148 
standard methods (mass range: 2,000 to 20,000 m/z) against either the default Bruker 149 
database or the association of the Bruker database and our own reference spectra. 150 
Accuracy of the identification was determined by a logarithmic score value resulting 151 
from the alignment of peaks to the best matching reference spectrum [5]. 152 
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Bacterial extracts of isolates selected for MSP creation were re-spotted 10 times onto a 153 
ground steel target and each spot was measured 3 times. The resulting 30 mass spectra 154 
were carefully analysed using the FlexAnalysis software (version 3.4; Bruker Daltonics) 155 
to yield a minimum of 20 spectra per isolate with a m/z shift of less than 0.05%. 156 
Selected spectra were then uploaded onto the MALDI BioTyper to create a single MSP 157 
for each isolate with the BioTyper MSP creation standard method. 158 
The MSP dendrogram was constructed using the correlation distance measure with the 159 
weighted linkage algorithm settings of the MALDI BioTyper software.  160 
rpoB-based cluster analysis as well as MLSA cluster analysis were performed as 161 
described elsewhere [3].  162 
RESULTS 163 
Spectral analysis 164 
Seventy-eight Acinetobacter isolates representative of A. baumannii, A. nosocomialis, 165 
A. pittii, A. dijkshoorniae, and A. seifertii were used to identify species-specific 166 
biomarker peaks using the Bruker ClinProTools software. Acquired spectra were loaded 167 
into ClinProTools and grouped into 5 different classes, one for each Acinetobacter 168 
species, and the average spectrum for each class was calculated. A detailed spectra 169 
analysis of each species was performed in the region between 2,000 and 10,000 m/z that 170 
concentrated the bulk of mass peaks, and several species-specific peaks ranging from 171 
2876 to 8857 m/z values were identified (Table 1), as were 6 peaks (4265, 4661, 5175, 172 
6090, 6948 and 9319 m/z) that were present in all isolates.  173 
For A. baumannii, a biomarker peak unique to this species and present in all isolates 174 
was located at 5747 m/z (Figure 1E), as described previously [5, 14, 16, 17]. Two 175 
additional peaks at 4244 and 8485 m/z, likely representing the single and double 176 
protonation states of the same protein, were also identified in all A. baumannii isolates 177 
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but these were also shared with some isolates of A. nosocomialis, as shown below. 178 
Spectra from all A. baumannii isolates were correctly identified as A. baumannii (100%) 179 
by the Bruker BioTyper using the default taxonomy database. 180 
For A. nosocomialis, several peaks unique to this species were identified. A pair of 181 
peaks at 4069 and 8135 m/z (Figure 1B and 1H), also likely corresponding to different 182 
protonation states of a single protein, were present in all isolates but one, with the latter 183 
isolate displaying a shifted version of the pair located at 4084 and 8165 m/z, 184 
respectively (data not shown), in good agreement with previous reports [14, 17]. A 185 
second pair of unique peaks was located at 4180 and 8358 m/z but it was present in only 186 
12 out of 24 isolates (Figure 1C and 1I).  187 
Bacterial identification using the default Bruker taxonomy database was able to identify 188 
as A. nosocomialis only 13 out of 24 isolates (54%), while the remaining isolates were 189 
misidentified as A. baumannii (46%). Similar inconsistent results regarding the 190 
identification of A. nosocomialis have also been reported by other authors [8, 13, 14]. 191 
The A. nosocomialis isolates that were correctly classified by the Bruker BioTyper 192 
software were clustered together (group I) and compared with those that were 193 
misidentified (group II). Spectra within each group showed very similar peak profiles 194 
but there were some significant differences between both groups (Figure 2D). 195 
As shown in Figure 2A and 2C, isolates in A. nosocomialis group I and II shared the A. 196 
nosocomialis species-specific peaks centred around 4069 and 8135 m/z. All but one 197 
isolate in group I also presented the other two species-specific peaks centred around 198 
4180 and 8358 m/z, which were absent among group II profiles. Instead, isolates in 199 
group II presented the two peaks at 4244 and 8485 m/z that were also present in all A. 200 
baumannii isolates, as mentioned before. 201 
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Despite the clear splitting of all A. nosocomialis isolates into two separate groups 202 
according to their peak signatures, this clear distinction was not observed by rpoB-based 203 
clustering (data not shown) or MLSA analysis (Figure 3).  204 
For A. pittii, the analysis of spectra recognised a higher degree of variability with only a 205 
few species-specific peaks shared by a majority of isolates. A major peak at 5777 m/z 206 
(Figure 1E) was identified in all isolates but one, in good agreement with previous 207 
reports [14, 16-18], and a second unique peak at 6692 m/z was present in 10 out of 15 208 
isolates (Figure 1F). Eight out of 15 isolates also showed a pair of peaks located at 209 
4411 and 8821 m/z, respectively, again likely representing the differently charged states 210 
of a single protein (Figure 1D and 1J). These two peaks were also identified in 2 211 
additional isolates although they were shifted to 4347 and 8691 m/z, respectively (data 212 
not shown). Similarities among A. pittii isolates at the spectra level did not correlate 213 
with either rpoB or MLSA clustering either (data not shown). Species identification 214 
using the default Bruker taxonomy database correctly identified all spectra as A. pittii, 215 
in agreement with previous reports [13, 14]. 216 
For A. dijkshoorniae, the analysis of spectra identified 4 masses that were present in all 217 
isolates and were also unique to this species: 3 major peaks located at 4430, 5788 and 218 
8857 m/z values (Figure 1D, 1E and 1J), as described previously [3], as well as a 219 
smaller peak at 6729 m/z (Figure 1F). Since there were no reference spectra for this 220 
novel Acinetobacter species in the Bruker taxonomy database, the best identification 221 
matches of spectra from A. dijkshoorniae isolates were to A. pittii reference spectra. 222 
Interestingly, the first two best matches were always to the same A. pittii reference 223 
spectra (A. pittii serovar 18 DSM9341 and serovar 22 DSM9318), with log scores >2.0, 224 
while the subsequent best matches against A. pittii isolates showed log scores <2.0. It is 225 
plausible that the two isolates originally used to create these MSPs belonged to the 226 
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novel A. dijkshoorniae species. Of note, the MSPs for these isolates were used to screen 227 
our Acinetobacter collection and led to the identification of 3 isolates that turned out to 228 
be A. dijkshoorniae by molecular methods. 229 
For A. seifertii, a unique peak was present at 7446 m/z (Figure 1G) in all isolates and 230 
several additional species-specific peaks were also identified, albeit with differences 231 
depending on the isolates. A pair of peaks located at 4194 and 8385 m/z (Figure 1C 232 
and 1I) was identified in all but 2 isolates that, nevertheless, presented a similar pair but 233 
shifted at 4122 and 8244 m/z (data not shown). Likewise, another pair of peaks located 234 
at 3948 and 7893 m/z (Figure 1A and 1H) was present in all but 3 isolates, the latter 235 
showing a shifted pair at 3985 and 7968 m/z (2 isolates) or 3961 and 7920 m/z (1 236 
isolate) (data not shown).  237 
As it occurred with A. dijkshoorniae, there were no reference spectra for A. seifertii in 238 
the Bruker taxonomy database either, and the best identification matches were to A. 239 
baumannii reference spectra. However, the first best match was always to the same A. 240 
baumannii reference spectra (A. baumannii CS_62_1 BRB) with log scores >2.0, while 241 
the subsequent best matches showed log scores <2.0. The MSP for A. baumannii 242 
CS_62_1 BRB was also used to screen our Acinetobacter collection and it led to the 243 
identification of one isolate that was confirmed as A. seifertii by molecular methods, 244 
again suggesting that the isolate used to create the MSP A. baumannii CS_62_1 BRB 245 
most likely belonged to the novel A. seifertii species.  246 
Generation and validation of pattern recognition models 247 
Spectra from a reference set of isolates (see Materials and Methods) were uploaded to 248 
the ClinProTools software and grouped again into 5 different classes according to each 249 
Acinetobacter species. The average spectra from each Acinetobacter species were used 250 
to generate classification models based on the Genetic Algorithm, SNN and Quick 251 
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Classifier algorithms to select an optimal set of peaks that allowed correct species 252 
allocation of the spectra used for model generation. All three algorithms provided 253 
recognition and cross-validation values above 95% and 87%, respectively, suggesting 254 
that successful differentiation of all 5 Acinetobacter species was possible. Of the three 255 
algorithms, the SNN model yielded the highest recognition and cross-validation values 256 
(100% and 92.6%, respectively) and was therefore selected to evaluate its ability to 257 
classify spectra from isolates not included in the generation of the model (external 258 
validation). The SNN model was able to allocate most of the spectra from the 38 259 
isolates of the validation set to their corresponding Acinetobacter species, resulting in a 260 
positive predictive value (PPV) of 96.8% (Table 2). 261 
BioTyper database update and automated identification 262 
As described in Materials and Methods, new BioTyper MSPs were created from 263 
representative isolates to account for the intra- and inter-species variability observed. 264 
MSPs for A. seifertii derived from isolates NIPH 973T (type strain), R00-JV54 and LUH 265 
05789. MSPs for A. dijkshoorniae originated from isolates JVAP01T (type strain) and 266 
R10-JV222. In addition, we included new MSPs for A. nosocomialis that derived from 267 
isolates SCOPE 150 and RUH 503, to account for the identification of A. nosocomialis 268 
isolates belonging to A. nosocomialis group II (Figure 2).  269 
Cluster analysis of MSPs from all the Acinetobacter species within the Acinetobacter 270 
calcoaceticus-Acinetobacter baumannii complex (which includes the Ab group) 271 
grouped MSPs from each Acinetobacter species into separate monophyletic clusters 272 
(Figure 4). Interestingly, the two MSPs from representative isolates of A. nosocomialis 273 
group II were grouped more closely to A. baumannii MSPs than to those of A. 274 
nosocomialis group I, while still forming a separate clade, also in good agreement with 275 
results from the spectral analysis.  276 
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Spectra from all 78 isolates were then analysed against a custom database that included 277 
the MSPs from all the Acinetobacter species within the default Bruker taxonomy 278 
database plus the novel reference signatures for A. seifertii, A. dijkshoorniae and A. 279 
nosocomialis. As shown in Table 2, the allocation of spectra obtained from bacterial 280 
extracts to their corresponding Acinetobacter species provided sensitivity and 281 
specificity values ranging from 98.8-100% and 99.6-100%, respectively, resulting in a 282 
PPV of 99.6%. In addition, strains RUH 204 (A. junii), RUH 44 (A. haemolyticus), 283 
RUH 45 (A. lwoffii), RUH 3517 (A. radioresistens), and RUH 584 (A. calcoaceticus), 284 
representing a set of reference Acinetobacter strains belonging to Acinetobacter species 285 
other than those included within the Ab group [5], were also correctly identified (data 286 
not shown). These results showed the absence of cross-identification between the novel 287 
MSPs and other Acinetobacter spp.  288 
Likewise, the identification of spectra from direct colonies instead of bacterial extracts 289 
yielded sensitivity and specificity values ranging from 91.7-100% and 98.0-100%, 290 
respectively, with a PPV of 96.8% (Table 2).  291 
DISCUSSION 292 
In the present study we have compared for the first time the spectral profiles of the 293 
current members of the Ab group, including the novel A. seifertii and A. dijkshoorniae 294 
species. Spectral analysis has allowed the identification of a conserved set of peaks that 295 
are present in all isolates and, therefore, are linked at least to the Ab group. Four of 296 
these peaks correspond to 4 out of the 5 peaks described by Sousa et al. as being 297 
specific to the Acinetobacter genus (4662, 5176, 6949 and 9323 m/z) [17]. We have 298 
found, however, that the peak described by Sousa et al. at 7435 m/z is present in all 299 
species except A. seifertii, which instead presents a unique peak at 7446 m/z. 300 
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The thorough analysis of all spectra has also led to the identification of several peaks 301 
that are unique to each Acinetobacter species and might serve for identification 302 
purposes. The majority of such peaks corroborate previous findings but, nevertheless, 303 
remarkable differences have also been found. For instance, previous studies have 304 
reported a peak at 2875 m/z as specific to A. baumannii [5, 19], although Sousa et al. 305 
reported such peak in A. nosocomialis [17]. In the present study, we have identified a 306 
peak at 2876 m/z in all A. baumannii isolates that overlaps with a small intensity peak 307 
centred around 2869 m/z present in some A. nosocomialis isolates. The presence of such 308 
a peak might be misleading for identification purposes (data not shown). Likewise, 309 
Hsueh et al. identified a peak at 2889 m/z that was unique to A. pittii [14] and in our 310 
study this peak is indeed present in all A. pittii isolates but it is also identified in several 311 
isolates of A. nosocomialis and A. dijkshoorniae; and a peak at 9542 m/z considered as 312 
unique to A. seifertii by Sousa et al. [17] is clearly present in several A. pittii and A. 313 
dijkshoorniae isolates in our study. 314 
In addition, the comprehensive examination of the A. nosocomialis isolates has led to 315 
their differentiation into two groups according to their spectra profiles. Isolates included 316 
in group I contain 4 A. nosocomialis-specific peaks while isolates in group II only show 317 
two of these peaks but share two additional peaks with A. baumannii. Interestingly, of 318 
the 5 reference spectra (MSPs) for A. nosocomialis included in the Bruker taxonomy 319 
database (Figure 3), 4 originated from isolates belonging to group I and only one was 320 
representative of group II. These differences together with the underrepresentation of 321 
group II MSPs in the default BioTyper software might account for the low rates of 322 
successful identification of A. nosocomialis isolates reported by several authors [8, 13, 323 
14]. 324 
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So far only two studies have confronted the ambiguous identification of certain isolates 325 
from the Ab group, either using alternative sample preparation protocols [16] or by 326 
coupling MALDI-TOF/MS with chemometric methods [17]. These novel approaches 327 
have certainly improved the differentiation of the former members of the Ab group, but 328 
they have failed to provide automated spectra acquisition linked to automated species 329 
identification and, therefore, cannot be successfully implemented in routine clinical 330 
laboratories. In addition, none of these studies have thoroughly evaluated the 331 
identification of the novel members of the Ab group, A. dijkshoorniae and A. seifertii.  332 
The results from the spectral analysis and the validation of the SNN pattern recognition 333 
model in our study suggest that conventional and automated MALDI-TOF/MS 334 
identification of all the current members of the Ab group is possible with an updated 335 
reference taxonomy database. We have created novel reference signatures (MSPs) to 336 
improve the identification of group II A. nosocomialis isolates as well as of the novel 337 
species A. dijkshoorniae and A. seifertii. Cluster analysis of the novel MSPs together 338 
with those already present in the default Bruker taxonomy database also support the 339 
unambiguous identification of all species using this technology. Of note, the MSPs from 340 
isolates A. pittii serovar 18 DSM9341 and A. pittii serovar 22 DSM9318 are clustered 341 
together with those of A. dijkshoorniae, and the MSP from A. baumannii CS_62_1 BRB 342 
is clustered together with the MSPs from A. seifertii isolates (Figure 4), emphasising 343 
that the species identification of these isolates should be revisited since the 344 
characterisation of novel Acinetobacter species. 345 
Bacterial identification by MALDI-TOF/MS using our custom taxonomy database has 346 
shown correct identification of all Acinetobacter species within the Ab group with 347 
sensitivity and specificity values well above 98% when using spectra from bacterial 348 
extracts, and above 91% and 98%, respectively, when using spectra directly from 349 
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bacterial colonies. It should be noted, however, that the quality of spectra with the use 350 
of direct colonies highly depends on technician expertise during sample loading, with 351 
identification rates varying greatly. 352 
Inclusion of these novel MSPs into the Bruker taxonomy database should allow rapid 353 
automated identification of all the Acinetobacter species within the group, contributing 354 
to the assessment of the clinical and epidemiological relevance of the different species 355 
in the Ab group and, eventually, improving the treatment and management of 356 
Acinetobacter infections [20]. 357 
We acknowledge that the small number of isolates included might have been a 358 
limitation in our study, in particular for A. pittii. A. pittii isolates show the largest 359 
variability, both regarding spectra profiles and genetic sequences, and although there is 360 
no cross-identification between A. pittii and other Acinetobacter spp., the inclusion of 361 
additional strains may contribute to further delineate this species. 362 
It is also clear from this study that achieving correct identification of bacterial species 363 
by MALDI-TOF/MS strongly relies on the accuracy and robustness of the reference 364 
database, which needs to be constantly refined and validated on a par with an evolving 365 
taxonomic classification. 366 
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TABLES 455 
TABLE 1. ClinProTools peak statistics for all the species-specific peaks 456 
 457 
Peak number Mass DAve PTTA PWKW PAD Abau Anos Apit Adij Asei 
21 3948.53 13.65 0.00344 0.0000533 < 0.000001      
23 4069.73 4.81 0.000539 < 0.000001 < 0.000001      
26 4180.56 9.36 < 0.000001 < 0.000001 < 0.000001      
27 4194.14 13.42 < 0.000001 < 0.000001 < 0.000001      
34 4411.95 11.99 < 0.000001 < 0.000001 < 0.000001      
35 4430.15 37.02 < 0.000001 < 0.000001 < 0.000001      
58 5747.48 137.56 < 0.000001 < 0.000001 < 0.000001      
59 5777.3 157.06 < 0.000001 < 0.000001 < 0.000001      
60 5788.92 101.76 < 0.000001 < 0.000001 < 0.000001      
78 6692.55 5.97 0.00000267 < 0.000001 < 0.000001      
80 6729.52 3.94 0.0000755 < 0.000001 < 0.000001      
88 7446.28 8.73 0.000984 0.0000173 < 0.000001      
89 7893.14 61.67 0.000187 < 0.000001 < 0.000001      
92 8135.43 33.8 < 0.000001 < 0.000001 < 0.000001      
96 8358.1 50.16 < 0.000001 < 0.000001 < 0.000001      
97 8385.13 53.54 < 0.000001 < 0.000001 < 0.000001      
101 8821.13 43.15 < 0.000001 < 0.000001 < 0.000001      
102 8857.63 103.26 < 0.000001 < 0.000001 < 0.000001      
Peak number: correlative numbering of the peak in the average spectra; Mass: m/z value; DAve: difference between the maximal and the minimal 458 
average peak area/intensity of all the species; PTTA: p value of t-/analysis of variance test; PWKW: p value of Wilcoxon/Kruskal–Wallis test 459 
(preferable for non-normally distributed data); PAD: p value of Anderson–Darling test, which gives information about normal distribution (p-460 
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value AD <0.05, non-normally distributed; p-value AD >0.05, normally distributed); Abau: A. baumannii; Anos: A. nosocomialis; Apit: A. pittii; 461 
Adij: A. dijkshoorniae; Asei: A. seifertii. Shaded boxes indicate species specificity. 462 
 463 
TABLE 2. External validation of the supervised neural network (SNN) model and the novel mean spectra (MSPs) using the ClinProTools and the 464 
MALDI BioTyper software, respectively. 465 
 466 
    Spectra classification    
Method Acinetobacter 
species 
Nº of 
Isolates 
Nº of 
spectra 
A. 
baumannii 
A. 
nosocomialis 
A. 
pittii 
A. 
dijkshoorniae 
A. 
seifertii 
Sen 
(%) 
Spe 
(%) 
PPV 
(%) 
ClinProTools A. baumannii 9 90 89 1 0 0 0 98.9 100 
96.8 
A. nosocomialis 11 110 0 110 0 0 0 100 96.7 
A. pittii 7 70 0 7 61 0 2 87.1 99.7 
A. dijkshoorniae 6 60 0 0 1 59 0 98.3 100 
A. seifertii 5 50 0 1 0 0 49 98.0 99.4 
BioTyper 
(Bacterial 
extracts) 
A. baumannii 16 160 158 2 0 0 0 98.8 99.8 
99.6 
 
A. nosocomialis 24 240 1 239 0 0 0 99.6 99.6 
A. pittii 15 150 0 0 150 0 0 100 100 
A. dijkshoorniae 12 120 0 0 0 120 0 100 100 
A. seifertii 11 110 0 0 0 0 110 100 100 
BioTyper 
(Direct 
colonies) 
A. baumannii 16 64 63 1 0 0 0 98.4 98.0 
96.8 
 
A. nosocomialis 24 96 5 91 0 0 0 94.8 99.5 
A. pittii 15 60 0 0 60 0 0 100 98.4 
A. dijkshoorniae 12 48 0 0 4 44 0 91.7 100 
A. seifertii 11 44 0 0 0 0 44 100 100 
 467 
Sen (%), sensitivity (%); Spe (%), specificity (%); PPV, positive predictive value 468 
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FIGURE CAPTIONS 469 
FIGURE 1. MALDI-TOF/MS averaged spectra plots from isolates of the Ab group 470 
showing specific peaks for: A. baumannii (red), A. nosocomialis (green), A. pittii (blue), 471 
A. dijkshoorniae (yellow) and A. seifertii (purple). The background noise signal is 472 
shown in orange. The x-axis shows the m/z values and the y-axis indicates the 473 
intensities of the peaks expressed in arbitrary intensity units. Peaks are ordered from left 474 
to right as A-J according to their ascending m/z values. 475 
 476 
FIGURE 2. Spectral analysis of A. nosocomialis and A. baumannii isolates. A. 477 
nosocomialis isolates are clustered into groups I and II according to BioTyper results. 478 
(A, B and C) Averaged spectra plots for all the spectra included within each group. A. 479 
baumannii (red), A. nosocomialis group I (blue), A. nosocomialis group II (green), 480 
background noise signal (orange). The x-axis shows the m/z values and the y-axis 481 
indicates the intensities of the peaks expressed in arbitrary intensity units. (D) Gel view 482 
representation in quadratic mode and chromatic scale of all independent spectra within 483 
the 4,000-9,000 m/z mass range. Each isolate is represented by 10 independent spectra. 484 
The x-axis shows the m/z values and the y-axis indicates the number of spectra (left) as 485 
well as intensities of the peaks expressed in arbitrary intensity units (right). Grey lines 486 
are used to separate spectra from different groups. Arrows indicate m/z values that are 487 
present in: A. nosocomialis group I and II (orange labels); only in A. nosocomialis group 488 
I (blue labels); in both A. nosocomialis group II and in A. baumannii (green labels); and 489 
only in A. baumannii (red label). 490 
 491 
FIGURE 3. Cluster analysis of all the 78 Ab group isolates included in the study based 492 
on the concatenated partial sequences of the cpn60, fusA, gltA, pyrG, recA, rplB and 493 
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rpoB genes used for MLST under the Pasteur scheme. The partial sequences of the 494 
individual genes used for MLSA can be retrieved from the PubMLST website 495 
(http://pubmlst.org/abaumannii/) under the sequence type codes listed in 496 
Supplementary Table S1. Phylogenetic trees were constructed using the neighbour-497 
joining method with genetic distances computed by Kimura’s two-parameter model 498 
(Kimura, 1980) with a bootstrap value of 1000 replicates. Bootstrap values (%) are 499 
indicated above the branches. The scale bar indicates sequence divergence. (A) 500 
Collapsed phylogenetic tree showing the monophyletic clustering of isolates from each 501 
Acinetobacter species within the Ab group. (B) Expanded phylogenetic tree showing 502 
the clustering of all the A. nosocomialis isolates. Circles (in blue) and squares (in green) 503 
indicate A. nosocomialis isolates classified as belonging to group I (correct BioTyper 504 
identification) or group II (BioTyper misidentification), respectively, using the default 505 
Bruker taxonomy database. The MSP label indicates isolates that originated the 5 506 
reference spectra (MSPs) for A. nosocomialis currently included in the default Bruker 507 
taxonomy database. 508 
 509 
FIGURE 4. MSP dendrogram containing all the MALDI-TOF/MS specific signatures 510 
of isolates from the Acinetobacter calcoaceticus-Acinetobacter baumannii complex 511 
included within the default Bruker taxonomy database as well as specific signatures for 512 
A. dijkshoorniae, A. seifertii and A. nosocomialis created in this study. Distance values 513 
are relative and normalised to a maximal value of 1,000. The novel MSPs created in this 514 
study are labelled with a single asterisk (*). MSPs from isolates that failed to cluster 515 
with their corresponding Acinetobacter species are labelled with a double asterisk (**). 516 
T: Type strain. 517 
 518 
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